U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07472114) titled 'Effect of tNGS on CAP Patients With Initial Treatment Failure' on March 10.
Brief Summary: This is a multicenter, randomized controlled trial designed to evaluate the impact of tNGS in patients with community-acquired pneumonia who experience initial treatment failure.
Study Start Date: April 10
Study Type: INTERVENTIONAL
Condition:
Community Acquired Pneumonia (CAP)
Intervention:
DIAGNOSTIC_TEST: Targeted next-generation sequencing
Bronchoalveolar lavage fluid (BALF) or sputum samples will be collected within 72 hours after randomization and sent for targeted next-generation sequencing (tNGS). The test results will be repor...